| Ytd | -50.28% | |
| 1y | -25.35% |
| Open | 9.09 | Prev Close | 9.20 | Low | 8.84 | High | 9.15 | Mkt Cap | 90.94M |
| Vol | 15.04K | Avg Vol | 69.32K | EPS | -1.54 | P/E | N/A | Forward P/E | -1.52 |
| Beta | 0.12 | Short Ratio | 7.11 | Inst. Own | 50.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 9.23 | 200-d Avg | 8.91 | 1yr Est | 16.33 |
ATRA News
Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly losses of $(0.32) per share which met the ana
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-ce
Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market ses
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-ce
CHICAGO, June 11, 2026 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a biopharmaceutical company focused
NEW YORK, May 26, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholder
Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors abou
LOS ANGELES, May 22, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors
New York, New York--(Newsfile Corp. - May 22, 2026) - Bronstein, Gewirtz & Grossman, LLC, a national
NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, r
NEW YORK--(BUSINESS WIRE)---- $ATRA #ATRA--Faruqi & Faruqi, LLP, a leading national securities law f
New York, New York--(Newsfile Corp. - May 21, 2026) - WHY: Rosen Law Firm, a global investor rights
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered L
NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been
NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recogniz
Atara stock soars 82% as the FDA outlines a regulatory pathway for its lead product candidate, tab-c
LOS ANGELES, May 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights li
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
New York, New York--(Newsfile Corp. - May 20, 2026) - WHY: Rosen Law Firm, a global investor rights
New York, New York--(Newsfile Corp. - May 20, 2026) - Bronstein, Gewirtz & Grossman, LLC, a national
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming May
Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly losses of $(0.29) per share which beat the an
https://www.sec.gov/Archives/edgar/data/1604464/000119312526219518/atra-424-b5-2026_q2.htm
Canaccord Genuity analyst John Newman upgrades Atara Biotherapeutics (NASDAQ:ATRA) from Hold to B
Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a leader in T-cell immunotherapy, leveraging its novel al
Lisata Therapeutics (LSTA) surged 20.3% to $5.03 in pre-market trading after agreeing to be taken pr
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel a
https://www.statnews.com/2026/02/25/rare-disease-drug-fda-ebvallo/?utm_campaign=rss
Canaccord Genuity analyst John Newman downgrades Atara Biotherapeutics (NASDAQ:ATRA) from Buy to
Four biotechnology stocks have surged into the top 10th percentile for momentum ranking, demonstrati
